3-Amino-5-methylisoxazole; 1072-67-9; 5-methylisoxazol-3-amine; 5-Methyl-3-isoxazolamine; 5-methyl-1,2-oxazol-3-amine; 3-Isoxazolamine, 5-methyl-; 5-Methyl-3-aminoisoxazole; Isoxazole, 3-amino-5-methyl-; 5-Methylisoxazol-3-ylamine; 3-Amino-5-methyl-isoxazole; MFCD00003155; 5-methyl-isoxazol-3-ylamine; G54MJS11L9; DTXSID9021631; NSC-159134; EINECS 214-013-6; NSC 159134; UNII-G54MJS11L9; AI3-62721; 3-AMINO-5-METHYLISOXAZOL; 3-AMINO-5-METHYL ISOXAZOLE; M3I; NSC159134; 5-methylisoxazole-3-amine; 3-amino-5-methylisooxazole; 3-amino 5-methyl isoxazole; 5-methyl-isoxazole-3-amine; 5-methyl-isoxazole-3-ylamine; DTXCID601631; CHEMBL3183354; 5-METHYL-3-ISOXAZOLYLAMINE; ACT07207; ALBB-021352; STR00406; Tox21_201149; STK793153; STL301718; ZINC16981047; 3-Amino-5-methylisoxazole, >=97%; 5-methyl-1,2-oxazol-3(2H)-imine; AKOS000119874; AKOS022103076; CS-W022416; NG-0401; PB28932; SDCCGMLS-0066220.P001; NCGC00248938-01; NCGC00258701-01; BP-10769; SY001097; CAS-1072-67-9; DB-014242; A0980; AM20080024; FT-0615010; EN300-21602; SULFAMETHOXAZOLE IMPURITY C [EP IMPURITY]; A801620; W-108757; Q27278772; F2190-0491; Z104503828